N-(2-{4-[6-(4-fluorophenyl)pyridazin-3-yl]-1,4-diazepan-1-yl}-2-oxoethyl)-N-[2-(morpholin-4-yl)ethyl]cyclopropanecarboxamide
Chemical Structure Depiction of
N-(2-{4-[6-(4-fluorophenyl)pyridazin-3-yl]-1,4-diazepan-1-yl}-2-oxoethyl)-N-[2-(morpholin-4-yl)ethyl]cyclopropanecarboxamide
N-(2-{4-[6-(4-fluorophenyl)pyridazin-3-yl]-1,4-diazepan-1-yl}-2-oxoethyl)-N-[2-(morpholin-4-yl)ethyl]cyclopropanecarboxamide
Compound characteristics
| Compound ID: | V023-1078 |
| Compound Name: | N-(2-{4-[6-(4-fluorophenyl)pyridazin-3-yl]-1,4-diazepan-1-yl}-2-oxoethyl)-N-[2-(morpholin-4-yl)ethyl]cyclopropanecarboxamide |
| Molecular Weight: | 510.61 |
| Molecular Formula: | C27 H35 F N6 O3 |
| Smiles: | C1CN(CCN(C1)c1ccc(c2ccc(cc2)F)nn1)C(CN(CCN1CCOCC1)C(C1CC1)=O)=O |
| Stereo: | ACHIRAL |
| logP: | 1.9984 |
| logD: | 1.9666 |
| logSw: | -2.2681 |
| Hydrogen bond acceptors count: | 8 |
| Polar surface area: | 69.489 |
| InChI Key: | GPYQOGVKDBAAKM-UHFFFAOYSA-N |